中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
Author:(Wenzhen DANG)

1.Efficacy of switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide combined with sofosbuvir/velpatasvir in treatment of previously untreated chronic hepatitis C patients with HIV/HCV co-infection and its influence on blood lipid levels

Bianli DANG ; Wenzhen KANG ; Mingyuan BI ; Jianhui LI ; Zhaoyun CHEN ; Shupeng LI ; Qing LIU ; Yongtao SUN ; Weiping CAI ; Wen KANG

Journal of Clinical Hepatology 2022;38(3):541-546

2.A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6.

Liping LIAO ; Wenzhen DANG ; Tingting LIN ; Jinghua YU ; Tonghai LIU ; Wen LI ; Senhao XIAO ; Lei FENG ; Jing HUANG ; Rong FU ; Jiacheng LI ; Liping LIU ; Mingchen WANG ; Hongru TAO ; Hualiang JIANG ; Kaixian CHEN ; Xingxing DIAO ; Bing ZHOU ; Xiaoyan SHEN ; Cheng LUO

Acta Pharmaceutica Sinica B 2022;12(11):4180-4192

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO